Works matching IS 17597706 AND DT 2022 AND VI 13 AND IP 2

Results: 14

Circulating tumor cell count: A reliable biomarker for treatment selection in metastatic breast cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 2, p. 265, doi. 10.1111/1759-7714.14269

By:

Li, Bingzhen;
Zheng, Ying

Publication type:

Article

Inhibitory effects of icotinib combined with antiangiogenic drugs in human non‐small cell lung cancer xenograft models are better than single target drugs.

Published in:

Thoracic Cancer, 2022, v. 13, n. 2, p. 257, doi. 10.1111/1759-7714.14261

By:

Jiang, Peng;
Zhang, Yan;
Cui, Jiadong;
Wang, Xiuxiu;
Li, Yu

Publication type:

Article

Correlation between clinicopathological characteristics of lung adenocarcinoma and the risk of venous thromboembolism.

Published in:

Thoracic Cancer, 2022, v. 13, n. 2, p. 247, doi. 10.1111/1759-7714.14260

By:

Zhang, Yuan;
Shi, Zhongyue;
Yi, Jiawen;
Zhao, Jin;
Zhang, Shu;
Feng, Wei;
Zhu, Min;
Hu, Bin;
Zhang, Yuhui

Publication type:

Article

Risk factors for in‐hospital mortality in patients with advanced lung cancer with interstitial pneumonia undergoing systemic chemotherapy: A retrospective and observational study using a nationwide administrative database in Japan.

Published in:

Thoracic Cancer, 2022, v. 13, n. 2, p. 236, doi. 10.1111/1759-7714.14254

By:

Shiraishi, Tomoko;
Oda, Keishi;
Yamasaki, Kei;
Kido, Takashi;
Sennari, Konomi;
Mukae, Hiroshi;
Ohtani, Makoto;
Fujino, Yoshihisa;
Matsuda, Shinya;
Fushimi, Kiyohide;
Yatera, Kazuhiro

Publication type:

Article

Improved survival in patients with unresectable stage III EGFR‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors.

Published in:

Thoracic Cancer, 2022, v. 13, n. 2, p. 182, doi. 10.1111/1759-7714.14237

By:

Wang, Sheng‐Yuan;
Lai, Ching‐Han;
Chen, Chian‐Wei;
Yang, Szu‐Chun;
Chang, Chao‐Chun;
Lin, Chia‐Ying;
Yen, Yi‐Ting;
Tseng, Yau‐Lin;
Su, Po‐Lan;
Lin, Chien‐Chung;
Su, Wu‐Chou

Publication type:

Article

Circulating cytokines associated with clinical outcomes in advanced non‐small cell lung cancer patients who received chemoimmunotherapy.

Published in:

Thoracic Cancer, 2022, v. 13, n. 2, p. 219, doi. 10.1111/1759-7714.14248

By:

Shi, Yuequan;
Liu, Xiaoyan;
Du, Juan;
Zhang, Dongming;
Liu, Jia;
Chen, Minjiang;
Zhao, Jing;
Zhong, Wei;
Xu, Yan;
Wang, Mengzhao

Publication type:

Article

Trend of lung cancer surgery, hospital selection, and survival between 2005 and 2016 in South Korea.

Published in:

Thoracic Cancer, 2022, v. 13, n. 2, p. 210, doi. 10.1111/1759-7714.14247

By:

Kim, Dohun;
Kang, Gil‐Won;
Jang, Hoyeon;
Cho, Jun Yeun;
Yang, Bumhee;
Yang, Hee Chul;
Hwang, Jinwook

Publication type:

Article

Utility of mass spectrometry and artificial intelligence for differentiating primary lung adenocarcinoma and colorectal metastatic pulmonary tumor.

Published in:

Thoracic Cancer, 2022, v. 13, n. 2, p. 202, doi. 10.1111/1759-7714.14246

By:

Shigeeda, Wataru;
Yosihimura, Ryuichi;
Fujita, Yuji;
Saiki, Hidekazu;
Deguchi, Hiroyuki;
Tomoyasu, Makoto;
Kudo, Satoshi;
Kaneko, Yuka;
Kanno, Hironaga;
Inoue, Yoshihiro;
Saito, Hajime

Publication type:

Article

Icaritin alleviates docetaxel‐induced skin injury by suppressing reactive oxygen species via estrogen receptors.

Published in:

Thoracic Cancer, 2022, v. 13, n. 2, p. 190, doi. 10.1111/1759-7714.14245

By:

Zou, Jie;
Xu, Meng‐Xia;
Li, Fang;
Wang, Yu‐Hao;
Li, Xiao‐Qian;
Yu, Dao‐Jiang;
Ma, Yi‐Jia;
Zhang, Yuan‐Yuan;
Sun, Xiao‐Dong

Publication type:

Article

Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial.

Published in:

Thoracic Cancer, 2022, v. 13, n. 2, p. 228, doi. 10.1111/1759-7714.14252

By:

Matsumoto, Hiromi;
Kobayashi, Nobuaki;
Somekawa, Kohei;
Fukuda, Nobuhiko;
Kaneko, Ayami;
Kamimaki, Chisato;
Kubo, Sousuke;
Tanaka, Katsushi;
Tagami, Yoichi;
Teranishi, Shuhei;
Watanabe, Keisuke;
Horita, Nobuyuki;
Hara, Yu;
Yamamoto, Masaki;
Kudo, Makoto;
Koizumi, Harumi;
Miura, Kenji;
Miyazawa, Naoki;
Kaneko, Takeshi

Publication type:

Article

Impact of docetaxel plus ramucirumab in a second‐line setting after chemoimmunotherapy in patients with non‐small‐cell lung cancer: A retrospective study.

Published in:

Thoracic Cancer, 2022, v. 13, n. 2, p. 173, doi. 10.1111/1759-7714.14236

By:

Ishida, Masaki;
Morimoto, Kenji;
Yamada, Tadaaki;
Shiotsu, Shinsuke;
Chihara, Yusuke;
Yamada, Takahiro;
Hiranuma, Osamu;
Morimoto, Yoshie;
Iwasaku, Masahiro;
Tokuda, Shinsaku;
Takeda, Takayuki;
Takayama, Koichi

Publication type:

Article

CircRNA circ_0008037 facilitates tumor growth and the Warburg effect via upregulating NUCKS1 by binding to miR‐433‐3p in non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 2, p. 162, doi. 10.1111/1759-7714.14235

By:

Yu, Jia;
Zhang, Haining;
Zhao, Chunsheng;
Li, Guanghui;
Zhang, Yingying;
Sun, Yang

Publication type:

Article

Robot‐assisted thoracic surgery versus video‐assisted thoracic surgery for treatment of patients with thymoma: A systematic review and meta‐analysis.

Published in:

Thoracic Cancer, 2022, v. 13, n. 2, p. 151, doi. 10.1111/1759-7714.14234

By:

Shen, Cheng;
Li, Jialong;
Li, Jue;
Che, Guowei

Publication type:

Article

Issue Information.

Published in:: Thoracic Cancer, 2022, v. 13, n. 2, p. 149, doi. 10.1111/1759-7714.14016
Publication type:: Article